|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue - related party | |||||
| Sales and marketing | |||||
| Research and development | |||||
| General and administrative | |||||
| Restructuring expense | |||||
| Loss from operations | |||||
| Other income | |||||
| Gain on sale of subsidiary | |||||
| Change in fair value of convertible debt | |||||
| Gain on debt forgiveness – related party | |||||
| Finance expense | |||||
| Interest expense | |||||
| Interest expense - RP | |||||
| Other expense | |||||
| Total other income (expense) | |||||
| Income (loss) before income tax | |||||
| Net loss | |||||
| Foreign currency translation gain (loss) | |||||
| Comprehensive loss | |||||
| Weighted average number of ordinary shares outstanding (in Shares) | |||||
| Revenue | |||||
| Nonrelated Party | |||||
| Related Party | |||||
| Total revenue | |||||
| Cost of revenue | |||||
| Gross profit | |||||
| Operating expenses: | |||||
| Sales and marketing | |||||
| Research and development | |||||
| Research and development – related party | |||||
| General and administrative (Note 2) | |||||
| Impairment of intangible asset | |||||
| Restructuring expense | |||||
| Total operating expenses | |||||
| Loss from operations | |||||
| Other income (expense) | |||||
| Other income | |||||
| Government grant | |||||
| Gain on sale of subsidiary | |||||
| Change in fair value of convertible debt | |||||
| Gain (loss) on sales and disposal of assets | |||||
| Interest expense | |||||
| Other expense | |||||
| Total other expense | |||||
| Loss before income tax | |||||
| Net loss | |||||
| Foreign currency translation adjustment | |||||
| Total comprehensive loss | |||||
| Basic loss per ordinary share (in Dollars per share) | |||||
| Diluted loss per ordinary share (in Dollars per share) | |||||
| Basic Weighted average number of ordinary shares outstanding (in Shares) | |||||
| Diluted Weighted average number of ordinary shares outstanding (in Shares) | |||||
Loading...